The goal of this activity is for clinicians involved in the care of patients with ovarian cancer to be better able to incorporate clinical trial data for newer ovarian cancer therapies, along with patient- and disease-related factors, into treatment planning; collaborate with the multidisciplinary team to engage patients in shared decision-making; and mitigate adverse events and quality-of-life concerns to optimize treatment outcomes.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/evolution-care-patients-advanced-ovarian-cancer-2023a1000x84
- Start Date: 2024-04-23 05:00:00
- End Date: 2024-04-23 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: GlaxoSmithKline - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest